Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-06

FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Mylan's original application for a generic combination tablet of doxylamine succinate and pyridoxine hydrochloride, used for nausea and vomiting in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (doxylamine succinate and pyridoxine hydrochloride)

Snippet

ORIG AP for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)